Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alessandra Maresca

Showing results (41-50 of 70) with videos related to

Pageof 7
Sort By:
Stem Cell Reports|July 30, 2021
The relevance of mitochondrial DNA variants fluctuation during reprogramming and neuronal differentiation of human iPSCsFlavia Palombo, Camille Peron, Leonardo Caporali, et al.
Research Square|November 14, 2023
Whole genome analysis of rare deleterious variants adds further evidence to BRSK2 and other risk genes in Autism Spectrum DisorderElena Bacchelli, Marta Viggiano, Fabiola Ceroni, et al.
Cell Reports|February 22, 2018
Pharmacological Inhibition of Necroptosis Protects from Dopaminergic Neuronal Cell Death in Parkinson's Disease ModelsAngelo Iannielli, Simone Bido, Lucrezia Folladori, et al.
Neurogenetics|November 12, 2015
Clinical and molecular study in a long-surviving patient with MLASA syndrome due to novel PUS1 mutationsMichelangelo Cao, Marta Donà, M Lucia Valentino, et al.
Journal of Cellular and Molecular Medicine|January 21, 2021
An increased burden of rare exonic variants in NRXN1 microdeletion carriers is likely to enhance the penetrance for autism spectrum disorderCinzia Cameli, Marta Viggiano, Magali J Rochat, et al.
Molecular Genetics and Metabolism|December 17, 2021
Molecular biomarkers correlate with brain grey and white matter changes in patients with mitochondrial m.3243A > G mutationStefania Evangelisti, Laura Ludovica Gramegna, Chiara La Morgia, et al.
NPJ Genomic Medicine|March 23, 2024
Genomic analysis of 116 autism families strengthens known risk genes and highlights promising candidatesMarta Viggiano, Fabiola Ceroni, Paola Visconti, et al.
Annals of Clinical and Translational Neurology|May 5, 2021
Brain MRS correlates with mitochondrial dysfunction biomarkers in MELAS-associated mtDNA mutationsLaura L Gramegna, Stefania Evangelisti, Lidia Di Vito, et al.
Human Pathology|May 14, 2013
Oncocytic glioblastoma: a glioblastoma showing oncocytic changes and increased mitochondrial DNA copy numberGianluca Marucci, Alessandra Maresca, Leonardo Caporali, et al.
EMBO Molecular Medicine|April 15, 2015
Homozygous NOTCH3 null mutation and impaired NOTCH3 signaling in recessive early-onset arteriopathy and cavitating leukoencephalopathyTommaso Pippucci, Alessandra Maresca, Pamela Magini, et al.
Pageof 7

Showing results (41-50 of 70) with videos related to

Sort By:
Pageof 7
Stem Cell Reports|July 30, 2021
The relevance of mitochondrial DNA variants fluctuation during reprogramming and neuronal differentiation of human iPSCsFlavia Palombo, Camille Peron, Leonardo Caporali, et al.
Research Square|November 14, 2023
Whole genome analysis of rare deleterious variants adds further evidence to BRSK2 and other risk genes in Autism Spectrum DisorderElena Bacchelli, Marta Viggiano, Fabiola Ceroni, et al.
Cell Reports|February 22, 2018
Pharmacological Inhibition of Necroptosis Protects from Dopaminergic Neuronal Cell Death in Parkinson's Disease ModelsAngelo Iannielli, Simone Bido, Lucrezia Folladori, et al.
Neurogenetics|November 12, 2015
Clinical and molecular study in a long-surviving patient with MLASA syndrome due to novel PUS1 mutationsMichelangelo Cao, Marta Donà, M Lucia Valentino, et al.
Journal of Cellular and Molecular Medicine|January 21, 2021
An increased burden of rare exonic variants in NRXN1 microdeletion carriers is likely to enhance the penetrance for autism spectrum disorderCinzia Cameli, Marta Viggiano, Magali J Rochat, et al.
Molecular Genetics and Metabolism|December 17, 2021
Molecular biomarkers correlate with brain grey and white matter changes in patients with mitochondrial m.3243A > G mutationStefania Evangelisti, Laura Ludovica Gramegna, Chiara La Morgia, et al.
NPJ Genomic Medicine|March 23, 2024
Genomic analysis of 116 autism families strengthens known risk genes and highlights promising candidatesMarta Viggiano, Fabiola Ceroni, Paola Visconti, et al.
Annals of Clinical and Translational Neurology|May 5, 2021
Brain MRS correlates with mitochondrial dysfunction biomarkers in MELAS-associated mtDNA mutationsLaura L Gramegna, Stefania Evangelisti, Lidia Di Vito, et al.
Human Pathology|May 14, 2013
Oncocytic glioblastoma: a glioblastoma showing oncocytic changes and increased mitochondrial DNA copy numberGianluca Marucci, Alessandra Maresca, Leonardo Caporali, et al.
EMBO Molecular Medicine|April 15, 2015
Homozygous NOTCH3 null mutation and impaired NOTCH3 signaling in recessive early-onset arteriopathy and cavitating leukoencephalopathyTommaso Pippucci, Alessandra Maresca, Pamela Magini, et al.
Pageof 7